[{"AccountsPayableCurrent_0_Q3_USD":2555000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-28169000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":9941000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":3418000.0,"RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_0_Q3_USD":null,"PropertyPlantAndEquipmentNet_0_Q3_USD":162000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":null,"ProceedsFromRelatedPartyDebt_3_Q3_USD":null,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3_Q3_USD":63512000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":127195000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2224000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":96000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":583000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":14000.0,"OtherNonoperatingExpense_3_Q3_USD":4000.0,"OtherNonoperatingExpense_1_Q3_USD":null,"OtherLiabilitiesCurrent_0_Q3_USD":180000.0,"OtherAssetsNoncurrent_0_Q3_USD":278000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.06,"OperatingLeaseRightOfUseAsset_0_Q3_USD":583000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":452000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":147000.0,"OperatingLeaseLiability_0_Q3_USD":599000.0,"OperatingLeaseExpense_3_Q3_USD":16000.0,"OperatingLeaseExpense_1_Q3_USD":16000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":16000.0,"OperatingIncomeLoss_3_Q3_USD":-14754000.0,"ShareBasedCompensation_3_Q3_USD":1189000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":null,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":126946000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":null,"StockholdersEquity_0_Q3_USD":179848000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.15,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":5.79,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":2800574.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":42442000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":4.35,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q3_shares":172729.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q3_USD":2873000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":5.79,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":2800574.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2571469.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":1738380.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.687,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.694,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.696,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.695,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":42442000.0,"OperatingIncomeLoss_1_Q3_USD":-6200000.0,"OperatingExpenses_3_Q3_USD":14754000.0,"OperatingExpenses_1_Q3_USD":6200000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.26,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.8,"Depreciation_3_Q3_USD":7000.0,"DeferredCosts_0_Q3_USD":0.0,"DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_0_Q3_shares":230000.0,"CommonStockValue_0_Q3_USD":2000.0,"CommonStockSharesOutstanding_0_Q3_shares":24410393.0,"CommonStockSharesIssued_0_Q3_shares":24410393.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":4768954.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":365000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":176305000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":180878000.0,"Cash_0_Q3_USD":1600000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":34000.0,"AssetsCurrent_0_Q3_USD":183102000.0,"Assets_0_Q3_USD":184125000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2800574.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":1189000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":845000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":845000.0,"AdditionalPaidInCapital_0_Q3_USD":208015000.0,"AccountsPayableRelatedPartiesCurrent_0_Q3_USD":9000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":180878000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":8800000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":0.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2782000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-14762000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-6184000.0,"NetIncomeLoss_3_Q3_USD":-14740000.0,"NetIncomeLoss_1_Q3_USD":-6184000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-14306000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-96000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":190707000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":179300000.0,"LiabilitiesCurrent_0_Q3_USD":3825000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":184125000.0,"Liabilities_0_Q3_USD":4277000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":62000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":18000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":206000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":216000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":661000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":18000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":16000.0,"InterestExpense_3_Q3_USD":null,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2121000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":278000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-33000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1654000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":4813000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":23885017.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":8180359.0,"Ticker":"AVTE","CIK":"1798749","name":"AEROVATE THERAPEUTICS, INC.","OfficialName":"Aerovate Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"409850498.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]